Patient safety is paramount. Our diligent pharmacovigilance practices ensure that our medications' safety profiles are continually reviewed and updated. Through systematic collection and analysis of data, we can detect, evaluate, and prevent adverse reactions, ensuring that any risks associated with our products are promptly addressed.
Our commitment to safeguarding medications is strengthened by our partnership with Pharmassist Ltd., a leading specialist in pharmacovigilance. Their expertise, combined with our dedication, allows us to rigorously monitor the safety of drugs, ensuring their benefits always outweigh the risks.
Regardless of one's status, be it a health professional or patient, feedback is pivotal. We highly value firsthand experiences and observations as they play a crucial role in the ongoing safety evaluation process.
Transparency is a core principle in our pharmacovigilance approach. We encourage the reporting of adverse reactions and ensure that every report is handled with the utmost confidentiality and professionalism. By allowing everyone to play a part in reporting, we foster an environment where our medicines' safety and efficacy are continually enhanced.
We view pharmacovigilance as more than a regulatory obligation—it's a moral one. It's our commitment to ensuring that our patients always have access to safe, effective medications. Through rigorous monitoring, collaboration, and transparency, we aim to instill trust and uphold our promise of safety to every individual relying on our products.
Should you wish to report an adverse reaction related to any of our products, please contact us through the appropriate channels:
- For Adaptoplast pharmaceutical products, please contact Pharmassist directly:
Tel.: 210-6560 700
Email: safe@pharmassist.gr
- For Vein Plus and Abilar pharmaceutical products:
Foteini Voukliza, Senior Drug Safety Officer, MSc
Tel.: +30 210 65 61 435 | 24 hours every day
Fax: 210 65 12 210
Email: pharmacovigilance@help.com.gr
- For all other Vican products:
Tel.: 210 2848001-4
Email: info@vican.gr
We assure you that all information regarding adverse event reporting is treated with utmost confidentiality and is recorded anonymously for both the reporter and the patient. Your trust and safety are our top priority.